Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 28;21(8):2315-22.
doi: 10.3748/wjg.v21.i8.2315.

Treatment of irritable bowel syndrome in China: a review

Chun-Yan Li  1 , Shu-Chuen Li  1
Affiliations
Review

Treatment of irritable bowel syndrome in China: a review

Chun-Yan Li et al. World J Gastroenterol. .

Abstract

Irritable bowel syndrome (IBS) is a common, chronic, functional gastrointestinal disorder with a high incidence rate in the general population, and it is common among the Chinese population. The pathophysiology, etiology and pathogenesis of IBS are poorly understood, with no evidence of inflammatory, anatomic, metabolic, or neoplastic factors to explain the symptoms. Treatment approaches are mainly focused on symptom management to maintain everyday functioning and to improve quality of life for patients with IBS. However, prescribed medications often result in significant side effects, and many IBS sufferers (particularly Chinese) do not improve. Instead of taking a variety of conventional medications, many have turned to taking traditional Chinese medicine or integrated Chinese and Western medicine for remedy. A number of clinical trials have shown that Chinese herbal, acupuncture or integrative therapies presented improved treatment outcomes and reduced side effects in IBS patients. The purpose of this review article is to examine the treatment approaches of IBS that have been published in recent years, especially in China, to assess the possible differences in treating IBS between China and other countries. This would provide some useful information of unique treatment approach in clinical practice for physicians in the management of IBS in China, thus offering more treatment options for IBS patients with potentially better treatment outcomes while reducing the medical cost burden.

Keywords: China; Integrated treatment; Irritable bowel syndrome; Traditional Chinese medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the treatment of irritable bowel syndrome in China. IBS: Irritable bowel syndrome; TCM: Traditional Chinese medicine.
See this image and copyright information in PMC

References

    1. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104 Suppl 1:S1–35. - PubMed
    1. Liu J, Hou X. A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China. J Gastroenterol Hepatol. 2011;26 Suppl 3:88–93. - PubMed
    1. Pan G, Lu S, Ke M, Han S, Guo H, Fang X. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling] Zhonghua Liu Xing Bing Xue Zazhi. 2000;21:26–29. - PubMed
    1. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. [A population-based epidemiologic study of irritable bowel syndrome in Guangdong province] Zhonghua Yi Xue Zazhi. 2004;84:278–281. - PubMed
    1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. - PubMed

MeSH terms

Substances